Homo sapiens
NRAS mutant melanoma cell line SKMEL30 treated with CDK4/6i (Palbociclib) 1?M and MEKi (Bnimetinib) 16 nM for 4 days
INSDC center name
Department of Life Science and Medecine
Submitter Id
S12/
batch
batch_2
cell_line
MELJUSO
cell_type
Melanoma
common name
human
inhibitors
CDK4/6i (Palbociclib) 1?M, MEKi (Bnimetinib) 110 nM
sample name
S12/
scientific_name
Homo sapiens
sex
female
time of treatment
Day4